23andMe’s genetic testing kit includes sending a saliva sample
Christopher Tripler / Alamy
Until recently, the American company 23andMe seemed to represent the promise of a new future of medicine, one in which genetic data could precisely guide individuals.
But earlier this year, it became clear that the company was in dire financial shape. Its value has fallen 96 percent from its 2021 high.. Does this mean that the potential of gene-based medicine is over-hyped, or are other factors at play?
23andMe – Named after the 23 pairs of chromosomes…
Source: www.newscientist.com
